Americana Partners, LLC Gilead Sciences, Inc. Transaction History

Americana Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $209,465 - $235,921	3,629 New	3,629 $224,000
Q1 2022 May 06, 2022	SELL	$57.92 - $72.58 $213,898 - $268,037	-3,693 Closed	0 $0
Q4 2021 Jan 28, 2022	SELL	$64.88 - $73.64 $90,248 - $102,433	-1,391 Reduced 27.36%	3,693 $268,000
Q3 2021 Nov 08, 2021	BUY	$67.69 - $73.03 $344,135 - $371,284	5,084 New	5,084 $355,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Americana Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Americana Partners, LLC with notifications on news.